Correo: bd@sidmexinovia.com
Teléfono: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Inicio >
Rasby 1.5 mg Injection
Rasby 1.5 mg Injection
Manufacturer/Marketed By : Intas Pharmaceuticals Ltd
$99.73 $62.14
Rasby 1.5 mg Injection is an effective treatment designed to manage elevated uric acid levels in the bloodstream, a condition referred to as hyperuricemia. This medication is particularly beneficial for...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Rasburicase 1.5 mg
Active Pharmaceutical Ingredient
Rasby 1.5 mg Injection
99,73 US$
62,14 US$
Rasby 1.5 mg Injection is an effective treatment designed to manage elevated uric acid levels in the bloodstream, a condition referred to as hyperuricemia. This medication is particularly beneficial for patients receiving chemotherapy for various cancers, including leukemia, lymphoma, and solid tumors, as well as those at risk for tumor lysis syndrome (TLS), a serious complication that can arise during cancer treatment. By converting uric acid into allantoin, a more soluble substance, Rasby facilitates easier excretion through the kidneys, thereby reducing the risk of complications associated with high uric acid levels. It is essential for patients to follow their healthcare provider's instructions closely, as proper dosage and monitoring are crucial for safety and effectiveness. While generally well-tolerated, potential side effects may include allergic reactions or kidney-related issues, making it important to report any unusual symptoms to a healthcare professional. Rasby 1.5 mg Injection stands out as a vital option for managing hyperuricemia in cancer patients, supporting their overall treatment journey with a focus on safety and efficacy. Always consult with a healthcare provider before starting any new medication to ensure it aligns with your individual health needs.
Active Pharmaceutical Ingredient
Usos
• Rasby 1 5 mg injection is primarily used to manage hyperuricemia that arises from tumor lysis syndrome (TLS). This condition often occurs after chemotherapy when rapid cell breakdown leads to elevated uric acid levels. By effectively lowering these levels, Rasby 1 5 mg injection helps prevent complications associated with high uric acid. It is particularly beneficial for patients undergoing aggressive cancer treatments.
• The administration of Rasby 1 5 mg injection can be crucial in oncology settings, especially for patients at high risk of TLS. When cancer cells are destroyed quickly, they release uric acid into the bloodstream, which can be harmful. By utilizing Rasby 1 5 mg injection, healthcare providers can mitigate the risk of renal impairment linked to elevated uric acid. This proactive approach helps ensure better outcomes during cancer therapies.
• Rasby 1 5 mg injection is also beneficial in the context of preventing gout attacks related to high uric acid levels. For patients who may develop elevated uric acid due to their cancer treatment, this injection offers a therapeutic solution. By controlling uric acid levels, Rasby 1 5 mg injection aids in reducing the risk of pain and inflammation associated with gout. This aspect makes it an important part of supportive care in oncology.
• In addition to its role in TLS, Rasby 1 5 mg injection can be utilized in various clinical scenarios where hyperuricemia is a concern. Its effectiveness in lowering uric acid levels makes it suitable for patients experiencing complications from their cancer treatments. The injection can help maintain uric acid within a safe range, thus protecting kidney function. This makes Rasby 1 5 mg injection a valuable tool in comprehensive cancer care.
Beneficios
Rasby 1.5 mg Injection is helpful for people who have to deal with too much uric acid, especially if they have certain types of cancer or are having chemotherapy. It works by lowering uric acid levels, which can relieve things like joint pain and swelling caused by too much uric acid in the body. It also helps to prevent problems such as kidney stones or damage caused by the formation of uric acid crystals. By tackling these problems, rasburicase helps people feel better overall and makes it easier for them to recover during treatment.
Efectos secundarios
Like all medicines, Rasby 1.5 mg Injection may cause side effects that do not require medical attention and will disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you're concerned about them.
Efectos secundarios más comunes
• Anxiety
• Fever
• Vomiting
• Joint pain
• Mouth sores/ulcers
• Swollen Limbs
• Injection site pain
Efectos secundarios comunes
• Yellowing Eyes
• Dark urine
• Bluish or Grey-coloured skin
• Injection site Pain
• Nausea
• Constipation
• Diarrhea
• Abdominal pain
• Throat pain
• Headche
Cómo utilizar
Using Rasby 1.5 mg Injection typically involves getting it through an intravenous (IV) infusion. A healthcare professional will administer it directly into your vein, usually in a hospital or clinic setting. The dosage and frequency of rasburicase injections will depend on your specific medical condition and your doctor's recommendations. It's essential to follow your healthcare provider's instructions carefully and attend all scheduled appointments for Rasby 1.5 Injection treatment. They'll monitor your response to the medication and adjust your treatment plan as needed to ensure the best results and minimize any potential side effects.
Consejos de seguridad
• Alcohol: Consuming alcohol may affect the effectiveness of Rasby 1.5 Injection. If you are taking rasburicase, it is recommended to stop consuming alcohol to ensure the medication works properly.
• Kidney: Rasby 1.5 mg Injection is safe for patients with kidney disease, and no dose adjustment is necessary. While taking Rasby 1.5 Injection, regular monitoring of blood tests may be recommended to ensure optimal health and effective treatment.
• Breastfeeding: It is unknown if Rasby 1.5 mg Injection passes into breast milk or how it might affect your baby. Please consult your doctor before breastfeeding if you are receiving Rasby 1.5 mg treatment.
• Liver: It is unknown whether Rasby 1.5 mg Injection can be used for patients with liver disorders. Inform your physician if you have any liver problems before starting treatment with Rasby 1.5 Injection.
• Pregnancy: It is unsafe to use Rasby 1.5 mg Injection during pregnancy. If you are pregnant or planning to become pregnant during the treatment, consult your doctor before taking Rasby 1.5 Injection.
• Driving: It is unsafe to drive vehicles or operate heavy machinery after taking Rasby 1.5 mg because it contains a small amount of alcohol, which may cause dizziness and impair your concentration.
Descargo de responsabilidad
Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.
Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.
Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.
Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.


